Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Immunology and Transplantation

Differential Impact of Chronic Hyperglycemia on Humoral Versus Cellular Primary Alloimmunity

  1. Nicholas H. Bishop1,
  2. Michelle K. Nelsen1,
  3. K. Scott Beard2,
  4. Marilyne Coulombe2 and
  5. Ronald G. Gill1,2⇑
  1. 1Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO
  2. 2Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO
  1. Corresponding author: Ronald G. Gill, ronald.gill{at}ucdenver.edu.
Diabetes 2017 Apr; 66(4): 981-986. https://doi.org/10.2337/db16-0218
PreviousNext
  • Article
  • Figures & Tables
  • Suppl Material
  • Info & Metrics
  • PDF
Loading

Article Figures & Tables

Figures

  • Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1

    No effect of chronic hyperglycemia on primary T-cell responses to alloantigen. A: PLN cell counts in alloimmunized mice. B: CD4+ and CD8+ cell counts in PLN. C: Frequency of responding Ki67+CD44hi cells in PLN. D: Geometric mean fluorescence intensity (gMFI) of IFNγ in Ki67+CD44hi cells. Black bars, B6; white bars, Akita. n = 6–8 per group from seven independent experiments. No significant differences after multiple Student t tests with Bonferroni-Dunn corrections.

  • Figure 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2

    No effect of chronic hyperglycemia on responses of either direct or indirect alloreactive TCR transgenic adoptively transferred cells. A: Number of direct (4C) and indirect (TCR75) alloreactive T cells in draining PLNs of Akita mice and euglycemic littermates 5 days after local alloimmunization. B: Frequency of proliferating (Ki67+) direct (4C) and indirect (TCR75) cells. C: Geometric mean fluorescence intensity (gMFI) of IFNγ in direct (4C) and indirect (TCR75) cells. Black circles, B6; white squares, Akita. Number of samples with no detectable cells in unchallenged mice indicated adjacent to “n.d.” n = 4 per group from four independent experiments. No significant differences between immunized groups after multiple Student t tests with Bonferroni-Dunn corrections.

  • Figure 3
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3

    No impact of chronic hyperglycemia on cellular responses to islet allografts. A: Survival curves of islet allograft acute rejection. n = 10–15. ***P < 0.001, Akita vs. SzB6; *P < 0.05, Akita vs. SzAkita; SzB6 vs. SzAkita not significant by nonparametric Mann-Whitney U test. B: Total numbers of graft-infiltrating cells at day 7. Numbers of CD4+ (C) and CD8+ T cells (D) within CD90+ graft-infiltrating cells. E: Frequency of responding Ki67+CD44hi cells within CD90+CD8+ graft-infiltrating cells. F: Geometric mean fluorescence intensity (gMFI) of IFNγ in CD90+CD8+FoxP3−Ki67+CD44hi T cells. G: Frequency of FoxP3+ cells within CD90+CD4+ graft-infiltrating cells. Ratio of CD90+CD4+FoxP3+ regulatory T cells to CD90+FoxP3−Ki67+CD44hi CD4+ (H) and CD8+ (I) effector T cells. Black circles, B6; white squares, Akita; black triangles, SzB6; white diamonds, SzAkita. In B–I, n = 4–6 per group from five independent experiments. Two-way ANOVA with Bonferroni corrections: **P < 0.01; ***P < 0.001; ****P < 0.0001.

  • Figure 4
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4

    Impaired humoral response to alloantigen in chronic diabetes. H-2d–expressing A20 target cells were exposed to serum from alloimmunized mice (A and B, n = 9–16 per group from four independent experiments) or islet allograft recipients (C and D, n = 4–8 per group from two independent experiments). A: Geometric mean fluorescence intensity (gMFI) of anti-IgM. B: gMFI of anti-IgG. C: gMFI of anti-IgM. D: gMFI of anti-IgG. Multiple Student t tests with Bonferroni-Dunn corrections: *P < 0.05; **P < 0.01; ***P < 0.001. Pre-TP, pretransplant.

PreviousNext
Back to top
Diabetes: 66 (4)

In this Issue

April 2017, 66(4)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by Author
  • Masthead (PDF)
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Differential Impact of Chronic Hyperglycemia on Humoral Versus Cellular Primary Alloimmunity
(Your Name) has forwarded a page to you from Diabetes
(Your Name) thought you would like to see this page from the Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Differential Impact of Chronic Hyperglycemia on Humoral Versus Cellular Primary Alloimmunity
Nicholas H. Bishop, Michelle K. Nelsen, K. Scott Beard, Marilyne Coulombe, Ronald G. Gill
Diabetes Apr 2017, 66 (4) 981-986; DOI: 10.2337/db16-0218

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Differential Impact of Chronic Hyperglycemia on Humoral Versus Cellular Primary Alloimmunity
Nicholas H. Bishop, Michelle K. Nelsen, K. Scott Beard, Marilyne Coulombe, Ronald G. Gill
Diabetes Apr 2017, 66 (4) 981-986; DOI: 10.2337/db16-0218
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Research Design and Methods
    • Results
    • Discussion
    • Article Information
    • Footnotes
    • References
  • Figures & Tables
  • Suppl Material
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • TLR9 Deficiency in B Cells Promotes Immune Tolerance via Interleukin-10 in a Type 1 Diabetes Mouse Model
  • Peptidylarginine Deiminase Inhibition Prevents Diabetes Development in NOD Mice
  • Differentiating MHC-Dependent and -Independent Mechanisms of Lymph Node Stromal Cell Regulation of Proinsulin-Specific CD8+ T Cells in Type 1 Diabetes
Show more Immunology and Transplantation

Similar Articles

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.